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The Correlation of Free Health Screenings at Community Pharmacies on Diabetes 
Anna M. Staudt, BSPS, PharmD Candidate; Jessica E. Amtower, BSPS, PharmD Candidate*; Jeniffer George, BS, PharmD Candidate;  
Nicholas C. Daniels, BSPS, PharmD Candidate; Jacques N. Allou, BBA, PharmD Candidate; Emily M. Laswell, PharmD, BCPS;  
John E. Ballentine, PharmD 
Cedarville University School of Pharmacy 
*This research was presented as a poster presentation at the 2016 ASHP Midyear Clinical Meeting. 
 
 
Abstract 
Objective: To assess the correlation of free health screenings in community pharmacies on patient perceptions of free health screenings 
and diabetes knowledge.  
Methods: The study design was a pre-post observational study using surveys, blood sugar screenings, and patient education on 
diabetes. Participants were voluntary patients from four REM Corporation pharmacies in Ohio who were 18 or older, not recently tested 
for diabetes, non-diabetic, not pregnant, and without disorders that could hinder survey responses and education. Pre- and post-surveys 
assessed both patient perceptions on free health screenings in community pharmacies and on diabetes knowledge. 
Results: Among the 26 participants there was no statistically significant difference between patient perception pre- and post-surveys 
(all p-values ≥0.05), however there was a statistically significant difference between pre and post diabetes knowledge surveys 
(p<0.001).  
Conclusion: Patients have positive opinions on free health screenings in community pharmacies and these screenings can help patients 
understand disease states and be more aware of their health. 
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Introduction 
Healthcare professionals can utilize health screenings to 
detect diseases early on in order to treat them more easily.1 
Screenings can be valuable in revealing health problems while 
minimizing unclear results and can be done routinely as a 
preventive measure or when there is reason to suspect a 
health problem exists.2,a Many easily-accessible community 
pharmacies hold free health screenings where walk-ins are 
welcome and screenings are convenient because no 
appointment is needed. Patients are recommended to follow-
up with a healthcare professional immediately when problems 
are identified during screenings.3 Free community health 
screenings that are available include blood glucose, blood 
pressure, and cholesterol. 
 
Extensive use of health screenings, specifically blood glucose 
checks, in a community setting could be beneficial. Diabetes is 
one of the most significant health issues Americans face today. 
Approximately 21 million individuals have been diagnosed 
with diabetes in the United States.4 An estimated 8.1 million 
more may be currently undiagnosed.4 Another concern is pre-
diabetes, as there are nearly 79 million people that are at 
greater risk for developing diabetes.5 Hyperglycemic events 
due to diabetes killed 2,361 in 2010 alone.4 Individuals who  
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suffer from this condition are subject to a wide array of other 
potential health problems, including being two to four times 
more likely to have heart disease and or a stroke.5 It is also the 
leading cause of blindness and kidney failure.5 Uncontrolled 
diabetes may also result in neuropathy and amputation if it 
continually goes unchecked.5 Blood glucose measurements are 
crucial given the aforementioned issues and need to be further 
explored due to the prevalence of diabetes. 
 
Previous literature has shown most studies regarding 
community pharmacy health screenings have been conducted 
on blood pressure and heart health related subjects. There has 
not been extensive research performed regarding patient 
knowledge of diabetes, as well as the correlation of health 
screenings. Assessments of risk factors for diabetes along with 
blood glucose screening measurements have been the main 
focus of many studies examining diabetes. Referral to a 
physician and the adherence of follow-up with a physician are 
crucial aspects of diabetes care.6,7 Some studies also explore 
individuals’ awareness of their risks for developing certain 
diseases.8 Research dealing with perceptions of free health 
screenings is limited, especially related to blood glucose health 
screenings and patient education and counseling. Researchers 
have examined satisfaction with the services provided during 
the health screenings, showing the majority of people believe 
pharmacies are convenient settings for health screenings and 
are satisfied with the services provided.3,9 
 
Research shows patients are receptive and willing to engage in 
free health screenings at community pharmacies, however, 
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more information is needed regarding diabetes-related health 
screenings. Most large studies to date on diabetes have 
focused only on risk factors. Patient education and knowledge 
or patient perceptions on blood glucose screenings have not 
been fully explored. This study will close the gaps in the 
previous research by assessing the correlation of free health 
screenings on patient knowledge.  
 
Objective 
The objective of this study was to assess the correlation of free 
health screenings in community pharmacies on patient 
perceptions of free health screenings and diabetes knowledge. 
The null hypothesis was blood glucose screenings and patient 
education on diabetes do not increase patient knowledge of 
diabetes or improve patient perceptions of health screenings. 
 
Methods 
This pre-post observational study began in October 2013 and 
ended in March 2016. Approval from the IRB at Cedarville 
University and permission from the American Diabetes 
Association to utilize information were granted in the fall of 
2014. Data collection began in March 2015 and ended in April 
2015. Data was analyzed in the spring of 2016. Funding was 
provided through Cedarville University School of Pharmacy 
research grants. Those providing research grants did not 
oversee or participate in the study. 
 
Setting 
Four REM Corporation pharmacies located in southern Ohio 
were used for this study to administer testing. Consent was 
given by the CEO of REM Corporation pharmacies as well as 
the pharmacy manager of each location. Pharmacies included 
were: Fayette Pharmacy, Fairfield Pharmacy, Lukas Pharmacy, 
and Town Drug. The study was conducted at two pharmacies 
each month. Each pharmacy was visited for three hours weekly 
for one month, making four total visits at each site. 
 
Study population 
Participants were selected based on purposive sampling. 
Those included in the study had to be age 18 or above, not 
previously diagnosed with diabetes, and not recently tested 
for diabetes. Participants were excluded if they were pregnant 
or had a learning disability that could hinder survey responses. 
 
Data collection 
Consent was obtained by each participant before taking part 
in the study. General patient information was recorded on a 
patient data form, including: full name, date of birth, sex, 
address, phone number, email address, medical history, 
weight, and current medications. Surveys, education, and 
blood glucose screenings were administered at each 
pharmacy. The surveys were created by the researchers of the 
study. Pre-surveys were administered after patient consent 
was obtained. The pre-surveys assessed both patient opinions 
of health screenings and knowledge on diabetes. The survey 
assessing patient perceptions used a 4-level agreement Likert-
type, with questions shown in Figure 1. Knowledge on diabetes 
was assessed using ten questions on diabetes as shown in 
Figure 2. Questions were created from information given by 
the American Diabetes Association. All information used to 
educate patients on diabetes came from an identical patient 
education sheet at each site made from information gathered 
from the American Diabetes Association to limit variability and 
bias. Patients also had blood sugar screened upon baseline 
assessment. It was recorded whether or not the patient had 
eaten or drunk anything except water in the past 8 hours. 
Blood glucose was then tested and recorded on the patient 
data form. A fasting blood glucose level above 100 mg/dL was 
considered high. If they had eaten or drank anything except 
water in the past 8 hours, random blood glucose levels above 
140 mg/dL were regarded as high. Patients were referred to 
the emergency department immediately if blood glucose 
levels were above 400 mg/dL with two consecutive tests. 
Identical post-surveys were sent to participants one month 
after their baseline screening either through mail or email. 
Patients had two weeks to fill out post-surveys and return 
them in the pre-stamped envelopes provided. Incentives were 
offered to patients who participated in the study based on the 
discretion of each individual REM Corporation pharmacy. 
 
Data Analysis 
A significance value of 0.05 was used for analyses. Power was 
set at 0.8. The Cohen’s d effect size was used to estimate the 
number of paired responses needed to reach power. A 
moderate difference between paired results was assumed, 
leading to a medium effect size assumption. Thirty-four paired 
responses were needed to reach power. 
 
Descriptive statistics were assessed for the study population. 
The descriptive statistics focused on location, sex, history of 
cardiovascular issues, and family history of diabetes. A 
Wilcoxon signed-rank test was used to analyze paired patient 
perception surveys. Paired diabetes knowledge surveys were 
analyzed using a McNemar test. Total correct responses to 
diabetes knowledge surveys between pre- and post-
assessments were analyzed using a paired t-test. Analyses 
were adjusted to exclude missing data. Statistical analyses 
were performed with the SPSS software version 23.0. 
 
Results 
Forty-six patients completed pre-surveys at the four 
pharmacies where research was conducted. However, one 
patient had to be excluded from data analysis since they had 
diabetes, resulting in a total of 45 participants being included. 
Twenty-six of the 45 responded to post-surveys either mailed 
or emailed to them a month later, giving a response rate of 
57.8%. Only 22 of the 26 post-survey respondents had 
completed both the patient perceptions of free health 
screenings and diabetes knowledge surveys. A flowchart of the 
patients included and survey responses are shown in Figure 3. 
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Descriptive statistics of the original 45 participants expressed 
differences in gender, comorbidities, and family history of 
diabetes, as shown in Table 1. The majority were female 
(64.4%) and 71.7% of participants had diseases other than 
diabetes, such as: heart disease, high blood pressure, kidney 
disease, depression, and anxiety. Related to cardiovascular 
issues, 60% had a history of heart disease, high blood pressure, 
or stroke. 
 
There were a total of 45 pre-surveys responses and 26 post-
survey responses. The number of answers to each question 
varied due to some questions being skipped by various 
participants. The percentages given were based on 45 pre-
survey and 26 post-survey participants and p-values were 
adjusted for missing pairs. A large majority of participants 
selected “agree” or “strongly agree” on both pre- and post-
surveys, meaning opinions were mostly positive overall. 
However, there was some variation for questions 6 and 8 on 
the pre-surveys. Exact percentages of responses for pre-
surveys and post-surveys are shown in Table 2 and Table 3, 
respectively. There were no statistically significant differences 
when comparing pre-survey and post-survey answers for each 
of the 8 questions. All p-values were greater than 0.05 and p-
values for each question can be seen in Table 4. 
There was a total of 45 respondents for the pre-surveys and a 
total of 22 for post-surveys. The percentages given were based 
on 45 pre-survey and 22 post-survey participants and p-values 
were adjusted for missing pairs. Results of the diabetes 
knowledge survey are shown in Table 5. Each question had a 
higher percentage of correct answers in post-survey than in 
pre-survey responses. However, there were only five 
questions that had statistically significant results between pre- 
and post-surveys. Questions 1, 6, and 8-10 had a significantly 
higher number of correct answers in post-survey results 
(p=0.008, 0.031, 0.031, 0.006, and 0.021, respectively). All 
other questions had p-values greater than 0.05. However, 
there was a statistically significant difference between total 
pre-knowledge and post-knowledge surveys with p<0.001. 
 
Each patient who participated had blood glucose tested to 
measure if they had abnormally high or low blood sugar levels. 
None of the patients tested for abnormally high or low blood 
sugar. 
 
Discussion 
The goal of this study was to determine the correlation of free 
community health screenings on both patient perceptions of 
free health screenings and diabetes knowledge. The majority 
of respondents agreed or strongly agreed in both pre- and 
post-surveys that health screenings in community pharmacies 
are beneficial, they were comfortable participating in free 
health screenings in community pharmacies, they are more 
aware of their health due to health screenings, and they would 
recommend family and/or friends to attend health screenings. 
 
However, a few respondents disagreed that community 
pharmacies are great locations for health screenings and that 
pharmacists are adequately qualified to administer screenings. 
Several of the participants also believe they are not more 
aware of their health due to health screenings. Due to these 
beliefs, they would not participate regularly in health 
screenings.  
 
Results of pre- and post-survey comparison regarding patient 
perceptions showed little change in patient opinions of such 
services. This can primarily be explained by the relatively 
positive outlook toward free health screenings shown in the 
pre-surveys. With highly positive baseline opinions of free 
screenings there was little opportunity for a statistically 
significant difference to be shown between the pre- and post-
surveys. This is encouraging for health professionals looking to 
participate in these types of activities in the future, as patients 
appeared receptive to participating. 
 
Limitations 
Data from this study must be interpreted with limitations 
being considered. One main limitation was the study not being 
adequately powered. Thirty-four paired responses were 
needed in order to reach power, but only 22 complete pre- and 
post-survey responses were received. Another limitation was 
there was no certain way to determine patients had not been 
diagnosed with diabetes or had recently been tested. This 
could have possibly skewed results by affecting the blood 
glucose testing and patient education. Recording the names of 
medications patients were taking helped reduce the risk of 
these threats to validity, since antidiabetic medications could 
easily be identified. There may also be an issue with lack of 
generalizability due to both the small sample size and small 
number of locations used in the study. Although the screenings 
were done in the pharmacies, there was also the issue of 
confidentiality. The screenings were done in an open area of 
the pharmacy and not in a private location. Providing coverings 
such as cubicles or screens may have helped put participants 
at ease and assure confidentiality. Studies have shown that 
participants are more likely to participate in screening or 
deliver health information to health care providers if there is 
respect and confidentiality.10 
 
Improvements could be made in the future to help strengthen 
the study. Future research could use a broader range of 
locations in order to maximize generalizability. More time to 
collect data would also be beneficial for future studies in order 
to get a larger sample size for better results. Future research 
should focus on improving patient knowledge of disease states 
and the correlation of patient education on overall health 
outcomes.  
 
Conclusion 
This study demonstrates that patients are receptive to the idea 
of free health screenings in community pharmacies and see a 
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benefit of the services that could be offered. The research also 
showed that knowledge can be gained through administering 
education during health screenings. Overall, free health 
screenings in community pharmacies can help patients 
understand disease states and be more aware of their health. 
 
Footnotes 
a FAQS.ORG. Health screening. 
http://www.faqs.org/health/topics/72/Health-
screening.html. Accessed September 18, 2013. 
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